Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Capital/Financing Update 2025

Jul 4, 2025

62369_rns_2025-07-04_14eac652-233d-4e4e-9ac7-38bee37e733c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

July 04, 2025

BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Exchange Plaza, Plot No. C/1, G Block Mumbai-400 001 Bandra-Kurla Complex, Bandra (E) Mumbai-400 051 Scrip ID-540025 Scrip Code-ADVENZYMES

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 – Incorporation of a Wholly Owned Subsidiary.

Ref – Outcome of Board Meeting dated May 13, 2025.

Pursuant to the Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 (as amended) (“SEBI Listing Regulations”), and in furtherance to the captioned letter dated May 13, 2025 intimating that the Board of Directors of the Company has approved incorporation of a wholly-owned subsidiary, we would like to share an update that the said wholly owned subsidiary of the Company has been incorporated in India as per the Certificate of Incorporation dated July 04, 2025.

The realevant details as required under the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 are enclosed as Annexure - A.

The above information is also made available on the website of the Company at https://www.advancedenzymes.com/investors/stock-exchange-compliance/#other-compliance

Kindly take a note of the same.

Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited

SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2025.07.04 15:37:59 +05'30'

Sanjay Basantani Company Secretary and Head – Legal

Annexure A

Name of the target entity, details in brief
such as size, turnover etc
Advanced Nutrazyme Private Limited;
Other details are not applicable as the said
wholly owned subsidiary is a newly
incorporated company in India and is yet to
commence its business.
Whether the acquisition would fall within
related party transaction(s) and whether
the promoter/ promoter group/ group
companies have any interest in the entity
being acquired? If yes, nature of interest and
details thereof and whether the same
is done at “arm’s length”
Not Applicable
Industry to which the entity being acquired
belongs
Nutrition and wellness
Objects and impact of acquisition (including
but not limited to, disclosure of reasons
for acquisition of target entity, if its business
is outside the main line of business of
the listed entity);
To carry on the business primarily of
Nutrition and wellness’ range of products.
Brief details of any governmental or
regulatory approvals required for the
acquisition
Not Applicable
Indicative time period for completion of the
acquisition
Not Applicable
Consideration - whether cash consideration
or share swap or any other form and
details of the same
Cash Consideration
Cost of acquisition and/or the price at which
the shares are acquired
The company has been incorporated with
initial subscribed share capital of₹5,00,000
i.e. 50,000 EquityShares of₹10 each
Percentage
of
shareholding
/
control
acquired and/or number of shares
100% shareholding
Brief background about the entity acquired
in terms of products/line of business
acquired, date of incorporation, history of
last 3 years turnover, country in which
the acquired entity has presence and any
other significant information(in brief)
The date of incorporation is July 04, 2025 –
the certificate of incorporation received by
the Company on July 04, 2025.
Other details are not applicable, as it’s a
newlyincorporated company.